Thorne is a gold-standard clinician brand, and this is its therapeutic-dose methylfolate: 1 mg (1,000 mcg) of L-5-MTHF, third-party tested. For someone with elevated homocysteine, a documented MTHFR variant, or a clinician's instruction to take a higher active-folate dose, it is a well-made, trustworthy choice. But read the dose honestly — 1 mg is well above the 400–800 mcg prenatal target, and for the general population that extra is neither needed nor proven to help. It ranks in the lower half because it pairs a premium price with a dose most women simply do not require, in a form without NTD-prevention evidence.